Clinical Trial Search Results - Adventist HealthCare

Skip to Content

Clinical Trial Search Results

Showing 1-8 of 8

Sorted By:

  • ERA 223

    Study to determine if the addition of radium-223 dichloride to standard treatment is able to prolong life and to delay events specific for prostate cancer.

  • IMbassador250

    Study evaluates the safety and efficacy of atezolizumab in combination with enzalutamide compared with enzalutamide alone in participants with mCRPC.

  • KEYNOTE-046

    Study of ADXS31-142 monotherapy and a combination of ADXS31-142 with Pembrolizumab (MK-3475) in patients with metastatic castration-resistant prostate cancer.

  • PRIMCAB

    Study to demonstrate the superiority in term of radiographic Progression-Free Survival (rPFS) of cabazitaxel in patients with metastatic Castration-Resistant Prostate Cancer.

  • REASSURE

    Study to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer patients.

  • SPARTAN

    The purpose of this study is to evaluate the efficacy and safety of ARN-509 in adult men with high-risk non-metastatic castration-resistant prostate cancer.

  • TITAN

    Study to determine if the addition of apalutamide to ADT provides superior efficacy in improving radiographic progression-free survival (rPFS).

  • VIABLE

    Study to determine whether DCVAC/PCa added onto Standard of Care Chemotherapy can improve survival times for patients with Metastatic Castration Resistant Prostate Cancer.

Page InfoPage
Showing trials 1-8 of 8

Clincal Trials & Research Studies

Local Health News - In Your Inbox

Join over 100k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!